HMP Global June 4, 2023

In his Psych Congress Elevate 2023 session “Expanding Treatment Options Through Psychedelics—What You Need to Know,” David S. Mathai, MD, postdoctoral research fellow, Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, took a deep dive into how clinicians can educate their patients about psychedelics and help them make informed decisions about their use.

In this Q&A, Dr Mathai gave Psych Congress Network a behind-the-scenes look into his session, the history of psychedelics, and why psychedelics represent a “unique psychiatric paradigm.”

Evi Arthur, Associate Digital Editor, Psych Congress Network: What were the main takeaways from your session “Expanding Treatment Options through Psychedelics – What You Need to Know”?

David S. Mathai, MD: There is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Interview / Q&A, Mental Health, Provider, Trends
Integrating Mental and Physical Health to Better Support Patients and Communities
Trauma-Informed Approach Enhances Substance Use Disorder Care, Appeals to Payers
Optum Behavioral Health Releases the First of Two Mass Overpayment Notices
Mental health crisis centers and EmPATH units: offering care that busy ERs can’t
Involuntary Medical Hold: The Next Step in Mental Health Parity?

Share This Article